Business

Notice of Results and Investor Presentation

Notice of Results and Investor Presentation.

articleOndine Biomedical, Inc.May 8, 20253/company/ondine-biomedical-inc/news/notice-of-results-and-investor-presentation-109
Notice of Results and Investor Presentation

About this update from Ondine Biomedical, Inc.

[{"type":"text","content":"\n\n8 May 2025\nONDINE BIOMEDICAL INC.\n(\"Ondine Biomedical\", \"Ondine\" or the \"Company\")\nNotice of Results and Investor Presentation\nOndine Biomedical Inc. (AIM: OBI) announces that it will publish its audited results for the year ended 31 December 2024 (\"Full Year Results\") and Annual Report 2024 on 15 May 2025.\nDr. Nicolas Loebel, President and Chief Technology Officer of the Company, will provide a live presentation relating to the Full Year Results via Investor Meet Company on 15 May 2025 at 16:30 BST (08:30 Pacific time).\nThe presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 14 May 2025, 09:00 BST (01:00 Pacific time), or at any time during the live presentation.\nInvestors can sign up to Investor Meet Company for free and add to meet ONDINE BIOMEDICAL INC. via: \nhttps://www.investormeetcompany.com/ondine-biomedical-inc/register-investor\nInvestors who already follow ONDINE BIOMEDICAL INC. on the Investor Meet Company platform will automatically be invited.\nA full overview of the 2024 fiscal year will be presented in the Annual Report 2024, which will be available on the Company's website on 15 May 2025 at: www.ondinebio.com/investors/reports-documentation/. The slides and recording of the live presentation will be posted to the same webpage as soon as available following the presentation, no later than 16 May 2025.\n \nEnquiries:\n\n\n\n\nOndine Biomedical Inc.\n\n\nwww.ondinebio.com\n\n\n\n\nCarolyn Cross, CEO \n\n\nVia Vane Percy & Roberts\n\n\n\n\n \nStrand Hanson Limited (Nominated & Financial Adviser)\n\n\n \n\n\n\n\nJames Harris, Richard Johnson\n\n\n+44 (0)20 7409 3494\n\n\n\n\n \n\n\n \n\n\n\n\nRBC Capital Markets (Broker)\n\n\n \n\n\n\n\nRupert Walford, Kathryn Deegan\n\n\n+44 (0)20 7653 4000\n\n\n\n\n\n\n\n \n\n\n\n\nVane Percy & Roberts (Media Contact)\n\n\n\n\n\n\n\nSimon Vane Percy, Amanda Bernard\n\n\n+44 (0)77 1000 5910\n\n\n\n\n \n \nAbout Ondine Biomedical Inc.\n \nOndine Biomedical Inc. is a Canadian life sciences company and leader in light-activated antimicrobial therapies (also known as 'photodisinfection'). Ondine has a pipeline of investigational products, based on its proprietary photodisinfection technol...

More updates from Ondine Biomedical, Inc.